4
Changes in Ownership
ACADIA PHARMACEUTICALS INC Filed Acc 0001209191-22-023737
Options or other derivatives
- CEO acquired 584,595 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| DAVIS STEPHEN CEO | 2022-04-05 | Grant or award · Stock Options (Right to Buy) | +237,931 | 237,931 | D | ||
| DAVIS STEPHEN CEO | 2022-04-05 | Grant or award · Restricted Stock Units | +69,333 | 69,333 | D | ||
| DAVIS STEPHEN CEO | 2022-04-05 | Grant or award · Restricted Stock Units | +277,331 | 277,331 | D | ||
Loading xslF345X03/doc4.xml…